Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

The author points out some major obstacles to effective scale-up and describes methods available to pharmaceutical scientists for addressing scalability issues.

Scale Up of Liquid and Semisolid Manufacturing Processes

In the manufacture of many pharmaceutical products, dry-particle blending is a critical step that directly affects content uniformity.

Scale Up of Powder-Blending Operations

Novartis to Expand Generics Business

CBER Draft Guidance for Spore-Formers and Plasmid Vaccines

CBER Draft Guidances for Spore-Formers and Plasmid Vaccines

Extrusion-spheronization and pellet compression are effective means of developing first-order kinetic, controlled-release drug delivery systems of azithromycin (AZI). The authors prepared, evaluated, and optimized AZI formulations and assessed the stability of the selected formulation under accelerated storage conditions.

Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin

Pharmaceutical Science & Technology Innovations

In the Spotlight-February 2005

Laser-Marking Technique Improves Tablet Branding

ISA-88 Automation Standard Gains IEC PAS Status

Albumin-Bound Nanoparticle Drug Nabs FDA Approval

MHRA to Reinspect Chiron Flu Vaccine Plant